Skip to main content

Conflicts at Calif. stem cell agency

Advocacy groups are calling for resignations from the board chairman of the California Institute for Regenerative Medicine (CIRM) and another CIRM board member in the wake of a violation of the institute's own conflict of interest rules. Meanwhile, California's state controller, John Chiang, has asked the state's Fair Political Practices Commission to investigate the allegations while his office conducts a financial audit of CIRM. The conflict of interest occurred in August, when John Reed, a

Written byBob Grant
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Advocacy groups are calling for resignations from the board chairman of the California Institute for Regenerative Medicine (CIRM) and another CIRM board member in the wake of a violation of the institute's own conflict of interest rules. Meanwhile, California's state controller, John Chiang, has asked the state's Fair Political Practices Commission to investigate the allegations while his office conducts a financial audit of CIRM. The conflict of interest occurred in August, when John Reed, a member of the CIRM's governing board, wrote a linkurl:letter;https://www.consumerwatchdog.org/resources/BIMRLetter.pdf to linkurl:Arlene Chiu,;https://www.the-scientist.com/news/display/53676/ then CIRM's chief scientific officer, opposing the denial of a CIRM grant to a researcher at the San Diego-area Burnham Institute for Medical Research. Reed, who is president and CEO of the Burnham Institute, wrote the seven page letter lobbying CIRM to reconsider its linkurl:denial;https://www.the-scientist.com/blog/display/53548/ of a $638,000 SEED grant to David Smotrich, a researcher affiliated with the Burnham Institute but also the founder and president of a San Diego-area infertility clinic. CIRM initially approved the grant, but later rejected the proposal based on the institute's rule that only full-time employees may receive state grants. CIRM's conflict of interest rules prohibit board members from participating in any grant award discussions that involve their home institutions. The letter was uncovered last month through a request for public documents made by David Jensen, author of the blog linkurl:California Stem Cell Report.;https://californiastemcellreport.blogspot.com/ In the letter Reed asserts that though Smotrich is not technically a full-time faculty member at Burnham, he participates in institute activities and accesses institute resources as if he were. Reed asks in the letter that CIRM "recognize the validity of Dr. Smotrich as a faculty member of the Burnham Institute for Medical Research, and to award the SEED grant that he rightfully deserves." Reed goes on to write, "I also wish to emphasize the potentially damaging consequences that a decision not to recognize Dr. Smotrich's legitimacy as a faculty member may have on clinician investigators, as it will surely discourage clinical researchers from participating in the CIRM mission to advance stem cell therapies." Robert Klein, the chairman of CIRM's governing board - the Independent Citizens Oversight Committee (ICOC) - has admitted that he linkurl:advised;https://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2007/11/22/BAPRTGU8P.DTL Reed to write the letter to clarify Smotrich's level of involvement at the Burnham Institute. "I told him to send them a letter to tell them what the correct facts were," Klein told the __San Francisco Chronicle__ last month. "I clearly did that." In a statement Emailed to __The Scientist__ today (Dec. 6), Reed wrote: "Because the ICOC had already made the decision to award the grant, it did not occur to me that conflict rules would prevent me from contacting staff to provide what I believed to be relevant information. I now understand that the conflict rules apply to the post-grant review process and I have not engaged in any further communications with CIRM regarding the Burnham grant." John Simpson, stem cell project director at the Foundation for Taxpayer and Consumer Rights, has called for both men to resign as has Jesse Reynolds, director of the Project on Biotechnology in the Public Interest at the Center for Genetics and Society. Simpson and Reynolds are both long-time critics of CIRM. California newspaper, __The Sacramento Bee__, published an linkurl:editorial;https://www.sacbee.com/110/story/515572.html last week suggesting that Klein step down. Simpson lodged a formal complaint with California's Fair Political Practices Commission last month regarding the conflict, and the commission is set to respond by Dec. 10. Commission spokesperson Roman Porter said that the commission will either move forward with an investigation of the incident, choose not to pursue an investigation, or ask for more time to consider the complaint.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo